Targeting Porphyromonas gingivalis virulence and viability with epimedokoreanin B prevents alveolar bone destruction in vivo
Bioscience, Biotechnology, and Biochemistry · 23.07.2026 · 90 (8) · 1064-1071
DOI: 10.1093/bbb/zbag075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, online erschienen am 27.05.2026. Verfasst von Toru Kariu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Shokei University, Chuo-ku, Kumamoto, Japan. Hauptthemen laut MEDLINE: Porphyromonas gingivalis, Alveolar Bone Loss, Flavonoids, Periodontitis. Die Arbeit nennt 21 Literaturangaben. Gefördert von: JSPS.
Abstract (Originalsprache)
Periodontal disease is a major oral infectious condition that leads to the degradation of alveolar bone and subsequent tooth loss. Porphyromonas gingivalis, a keystone pathogen in periodontitis, plays a critical role in disease initiation and progression. In a previous study, we demonstrated the anti-P. gingivalis activity of epimedokoreanin B, a prenylated flavonoid derived from Epimedium species. However, its in vivo efficacy against periodontitis remains unclear. Oral administration of epimedokoreanin B attenuated P. gingivalis-induced alveolar bone resorption in murine periodontitis models and suppressed infection-induced antibody production. Furthermore, epimedokoreanin B compromised bacterial membrane integrity and virulent gene expressions. In this preclinical study, in vitro and in vivo analyses indicate that epimedokoreanin B suppressed both bacterial viability and virulence, thereby attenuating alveolar bone loss caused by periodontitis. These findings suggest that epimedokoreanin B is a promising candidate for the development of novel therapeutics targeting periodontal pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Science, Shokei University, Chuo-ku, Kumamoto, Japan.
- Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.
Förderung
- JSPS
Zitieren
APA
Kariu, T., Nakashima, K., & Ikeda, T. (2026). Targeting Porphyromonas gingivalis virulence and viability with epimedokoreanin B prevents alveolar bone destruction in vivo. Bioscience, Biotechnology, and Biochemistry, 90(8), 1064-1071. https://doi.org/10.1093/bbb/zbag075
Vancouver
Kariu T, Nakashima K, Ikeda T. Targeting Porphyromonas gingivalis virulence and viability with epimedokoreanin B prevents alveolar bone destruction in vivo. Bioscience, Biotechnology, and Biochemistry. 2026;90(8):1064-1071. doi:10.1093/bbb/zbag075
BibTeX
@article{Kariu2026,
author = {Kariu, Toru and Nakashima, Keisuke and Ikeda, Tsuyoshi},
title = {Targeting Porphyromonas gingivalis virulence and viability with epimedokoreanin B prevents alveolar bone destruction in vivo},
journal = {Bioscience, Biotechnology, and Biochemistry},
year = {2026},
volume = {90},
number = {8},
pages = {1064--1071},
doi = {10.1093/bbb/zbag075}
}
EUVIMED